Diabetes Mellitus, Type 2
Conditions
Interventions
This is a randomized, double-blind clinical trial with four groups. Group A consists of 20 elderly individuals with Type 2 Diabetes Mellitus (T2DM) who will perform physical exercises and receive prot
G11.427.410.698.277
Sponsors
Universidade São Judas Tadeu
Universidade São Judas Tadeu
Eligibility
Age
65 Years to 79 Years
Inclusion criteria
Inclusion criteria: Stable dose of medication (oral antidiabetics or insulin or combination of both) for three or more months; glycated hemoglobin between 6 and 10.0%; renal function assessed by the Modification of Diet in Renal Disease (MDRD) above 60 ml/h; Aspartate Aminotransferase (AST) and Alanine Aminotransferase (ALT) up to 2.5 times the upper limit of the method; no impairment of the musculoskeletal system, disabling disease or previous surgeries that would prevent the exercise; no chronic non-communicable disease not adequately treated and decompensated, especially systemic arterial hypertension (SAH); does not use a pacemaker; age between 65 and 79 years; both sexes
Exclusion criteria
Exclusion criteria: Impossibility of carrying out evaluations and reevaluations and during the period; having more than three consecutive absences
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Expected outcome 1: To evaluate the effects of Whole-Body Electrostimulation combined with Protein Supplementation on physical capacities, hypertrophy, glycemic control, and the reduction of advanced glycation end products.;Observed outcome 1: Protein supplementation combined with whole-body electrostimulation training improved mobility and reduced body mass. It did not enhance muscle strength and hypertrophy, glycemic levels, physical capacities, or advanced glycation end products in older adults living with T2DM. | — |
Secondary
| Measure | Time frame |
|---|---|
| No secondary outcomes were expected. | — |
Countries
Brazil
Contacts
Public ContactAlessandra Belini
Universidade São Judas Tadeu
Outcome results
None listed